Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03428009 · ClinicalTrials.gov registry record

Dystonia Genotype-Phenotype Correlation

A clinical trial of Dystonia and Dystonia Disorder, sponsored by University of Texas Southwestern Medical Center.

Recruiting
Registry status
200
Enrollment target
1
Study location

NCT03428009: Recruiting study of Dystonia and Dystonia Disorder, sponsored by University of Texas Southwestern Medical Center.

NCT03428009 is a study of Dystonia and Dystonia Disorder that is actively recruiting participants, run by University of Texas Southwestern Medical Center. The registered enrollment target is 200 participants, below the 533-participant average among 28 other Dystonia trials with a reported enrollment target (62% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03428009, a study of Dystonia and Dystonia Disorder, is actively recruiting participants, sponsored by University of Texas Southwestern Medical Center.

RECRUITING
Registry status
200 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to (1) investigate the effect of known dystonia-causing mutations on brain structure and function, to (2) identify structural brain changes that differ between clinical phenotypes of dystonia, and to (3) collect DNA, detailed family history, and clinical phenotypes from patients with idiopathic dystonia with the goal of identifying new dystonia-related genes. Investigators will be recruiting both healthy control subjects and subjects with any form of dystonia. For this study there will be a maximum of two study visit involving a clinical assessment, collection of medical and family history, task training session, an MRI using the learned tasks, and finally a blood draw for genetic analysis. In total, these visits will take 3-5 hours. If the dystonia subjects receive botulinum toxin injections for treatment, the participants and their matched controls will be asked to come for a second visit.

Primary Outcome

Identify structural or functional imaging measures that distinguish (a) dystonia patients from matched controls, (b) between clinically-defined forms of dystonia

Interventions

  • OTHER Magnetic Resonance Imaging

Study Locations (1)

Texas

  • University of Texas Southwestern Medical Center - Dallas

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2018-03-01
Est. Completion 2027-09

What NCT03428009 shows while recruiting

NCT03428009 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 533-participant average among 28 other Dystonia trials with a reported enrollment target (62% lower).

The record links to 10 conditions, with Dystonia appearing as the primary indexed condition, and to 1 intervention - of which Magnetic Resonance Imaging is the first listed.

NCT03428009 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT03428009 about?

NCT03428009 is a clinical study titled "Dystonia Genotype-Phenotype Correlation". The purpose of this study is to (1) investigate the effect of known dystonia-causing mutations on brain structure and function, to (2) identify structural brain changes that differ between clinical phenotypes of dystonia, and to (3) collect DNA, detailed family history, and clinical phenotypes from ...

What is the current status of trial NCT03428009?

This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2018-03-01. Estimated completion is 2027-09.

What conditions does trial NCT03428009 study?

This clinical trial studies the following conditions: Dystonia, Dystonia Disorder, Dystonia, Secondary, Dystonia; Idiopathic, Dystonia, Primary.

What interventions are being tested in trial NCT03428009?

The interventions under investigation include: Magnetic Resonance Imaging (OTHER).

Who is sponsoring clinical trial NCT03428009?

This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03428009 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dystonia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03428009's enrollment target sits among peer trials

200 7th of 28 higher than 21 of 28 other Dystonia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Dystonia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03428009, the US trial registry maintained by the National Library of Medicine. NCT03428009 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.